National Institutes of Health (NIH)

NIH trial of rectal microbicide for HIV prevention begins in the United States

Study will assess safety and acceptability of rectal douche for pre-exposure prophylaxis.

NIH-funded study suggests standards would range from no cost to $11.84 per child.

Findings could point to new ways to treat RAS-driven cancers.

Such an algorithm may save clinicians time and accelerate clinical enrollment and research.

Research needed to establish best diagnostic and management strategies for increasingly common condition.

NIH-funded study provides clarity on safety of two common antiseizure drugs lamotrigine and levetiracetam.

NIH study finds some abnormal results due to colorectal, breast, lung and pancreatic cancers.

NIH modeling study looked at the individual and combined impacts of cancer prevention, screening, and treatment.

NIH-funded study finds risk of human infection continues to remain low.

Study Examined Tecovirimat in Countries Affected by Global Clade II Mpox Outbreak.